CULLETTA, Giulia
CULLETTA, Giulia
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors
2018-01-01 Tutone, M.; Culletta, G.; Garon, A.; Almerico, A.
Design, synthesis, biological evaluation,and molecular modeling of inhibitors of enzymes involved in tumor and viral pathologies
2022-12-14 Culletta, Giulia
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics
2021-01-01 Culletta, G.; Zappalà, Maria; Ettari, Roberta; Almerico, A. M.; Tutone, M.
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach
2020-01-01 Culletta, Giulia; Rita Gulotta, Maria; Perricone, Ugo; Zappala', Maria; Maria Almerico, Anna; Tutone, Marco
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods
2021-01-01 Culletta, Giulia; Zappala', Maria; Ettari, Roberta; Maria Almerico, Anna; Tutone, Marco
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity
2022-01-01 Culletta, G.; Allegra, M.; Almerico, A. M.; Restivo, I.; Tutone, M.
Sulfonamide Moiety as “Molecular Chimera” in the Design of New Drugs
2023-01-01 Culletta, G.; Tutone, M.; Zappala', M.; Almerico, A. M.
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING
2019-01-01 Tutone, M; Culletta, G; Livecchi, L; Almerico, Am
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri
2019-01-01 Campofelice, A; Culletta, G; Tutone, M; Pibiri, I; Lentini, L; Pace, A; Almerico, Am